Suzanne Shusterman, MD
Basic profileDana-Farber/Boston Children's Cancer and Blood Disorders Center
Suzanne Shusterman is an Oncology physician affiliated with Dana-Farber/Boston Children's Cancer and Blood Disorders Center. OpenAlex indexes 123 publications with 3,015 citations (h-index 29); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Sponsor: National Cancer Institute (NCI)
- Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Sponsor: Children's Oncology Group
- Project: Every Child for Younger Patients With Cancer
Sponsor: Children's Oncology Group
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- STK11 Adnexal Tumor in an Adolescent Female: Diagnostic Pitfalls of a Recently Described Entity
Pediatric and Developmental Pathology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Dubois, MD
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Rani George, MD, PhD
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Yoav Binenbaum, MD, PhD
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Natasha Archer, MD
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”